CRON doesn't and didn't have 1 Billion+ shares outstanding, so when it got its $2 Billion investment from Altria, this money was spread among fewer shares which resulted in a higher price increase per share. The $2 billion investment in ACB would result in only a $2 share price increase. Or say ACB was lucky enough to get the $4 billion that Canopy got, it would only result in a $4 increase per share. This is why the outstanding share float matters, and the reason why ACB won't make it to these levels for a long time (if ever - depending on how long it stays in business for). Shareholders were the ones footing the bill for all these silly acquisitions ACB has been making.
A $30 price target would mean the company would be worth over $30 billion, which is almost triple what it is now. Considering that 90%+ of ACBs revenues will be coming from Canada over the next 5 years and ACB is not competitive in the Canadian market (doesn't have any of the best or most popular products and its products are higher priced), it will be difficult for it to reach these levels.
News 
Market Data 
Discover 
AI
